EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:757316 |
| ChEBI Name | lirentelimab |
| Stars | |
| Last Modified | 30 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lirentelimab (CHEBI:757316) has role dermatologic drug (CHEBI:50177) |
| lirentelimab (CHEBI:757316) has role ophthalmology drug (CHEBI:66981) |
| lirentelimab (CHEBI:757316) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| lirentelimab | WHO MedNet |
| Synonyms | Source |
|---|---|
| AK-002 | ChEMBL |
| AK002 | ChEMBL |
| Antolimab | ChEMBL |
| Monoclonal antibody ak002 | ChEMBL |